A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation

Autor: Webster, Lynn, Dhar, Sunita, Eldon, Michael, Masuoka, Lorianne, Lappalainen, Jaakko, Sostek, Mark
Zdroj: In Pain September 2013 154(9):1542-1550
Databáze: ScienceDirect